Clinicians' opinions on new vaccination programs implementation

Vaccine

Volumn 30, Issue 31, 2012, Pages 4632-4637

  Dube E ^a,b,c   Gilca, V ^a,b,c   Sauvageau, C ^a,b,c   Bettinger, J A ^d,e   Boucher, F D ^b   McNeil, S ^f   Gemmill, I ^g   Lavoie, F ^b   Ouakki, M ^a   Boulianne, N ^a,b,c  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e BC CHILDREN S HOSPITAL   (Canada)

^f Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

^g Kingston   (Canada)

Author keywords

Attitudes; Knowledge; New vaccines; Physicians; Practices

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; WART VIRUS VACCINE;

ARTICLE; CANADA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; E-MAIL; FEASIBILITY STUDY; FEMALE; GENERAL PRACTITIONER; HEALTH PRACTITIONER; HEALTH PROGRAM; HUMAN; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; RANDOM SAMPLE; VACCINATION;

ATTITUDE OF HEALTH PERSONNEL; CANADA; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; PHYSICIANS; POLIOVIRUS VACCINE, INACTIVATED; QUESTIONNAIRES; VACCINES, CONJUGATE;

EID: 84861988532     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.100     Document Type: Article

References (34)

1. Mulholland E.K., Bjorvatn B. Introduction of new vaccines in the healthcare system 2003, The Vaccine Book, U.S.A., p. 391-410. B.R. Bloom, P.-H. Lambert (Eds.).
2. Levine M.M., Levine O.S. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use. Lancet 1997, 350(November):1386-1392.
3. Francois G., Duclos P., Margolis H., Lavanchy D., Siegrist C.A., Meheus A., et al. Vaccine safety controversies and the future of vaccination programs. Pediatric Infectious Disease Journal 2005, 24(11):953-961.
4. Batson A. Sustainable introduction of affordable new vaccines: the targeting strategy. Vaccine 1998, 16:S93-S98.
5. Plotkin S.A. Vaccines: past, present and future. Nature Medicine 2005, 11(Suppl. 4):S5-S11.
6. Erickson L.J., De Wals P., Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005, 23(19):2470-2476.
7. Piso B., Wild C. Decision support in vaccination policies. Vaccine 2009, 27(43):5923-5928.
8. Bryson M., Duclos P., Jolly A., Bryson J. A systematic review of national immunization policy making processes. Vaccine 2010, 28(Suppl. 1):A6-A12.
9. Houweling H., Verweij M., Ruitenberg E.J. Criteria for inclusion of vaccinations in public programmes. Vaccine 2010, 28(17):2924-2931.
10. Taylor J.A., Darden P.M., Brooks D.A., Hendricks J.W., Baker A.E., Wasserman R.C. Practitioner policies and beliefs and practice immunization rates: a study from Pediatric Research in Office Settings and the National Medical Association. Pediatrics 2002, 109(2):294-300.
11. Dionne M., Boulianne N., Duval B., Lavoie F., Laflamme N., Carsley J., et al. Manque de conviction face à la vaccination chez certains vaccinateurs québécois. Revue can Santé Publique 2001, 92(2):100-104.
12. Schmitt H.J., Booy R., Aston R., Van Damme P., Schumacher R.F., Campins M., et al. How to optimize the coverage rate of infant and adult immunizations in Europe. BMC Medicine 2007, 5:11.
13. Marchetti F., Morelli P. Measuring public health officers' opinions on new vaccination programs by means of the WHO Vaccine Introduction Guidelines. Human Vaccines 2009, 5(9):640-644.
14. Gilca V., Sauvageau C., McNeil S., Gemmill I.M., Dionne M., Dobson S., et al. Setting priorities for new vaccination programs by using public health officers and immunization managers opinions. Vaccine 2008, 26(33):4204-4209.
15. Gilca V., Boulianne N., Dube E., Sauvageau C., Ouakki M. Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire survey. International Journal of Nursing Studies 2009, 46(9):1219-1235.
16. Lavergne B., Frappier-Davignon L. Essai clinique de trivirix (R) pour l'immunisation contre la rougeole: les oreillons et la rubéole. The Rational Hybrid Monte Carlo 1986, 12(19):85-88.
17. Public Health Agency of Canada, Canadian Human Papillomavirus Vaccine Research Priorities Workshop - Final Report. CCDR, 2005. 32S1: p. 66.
18. Comité sur l'immunisation du Québec, évaluation de la pertinence d'un programme d'immunisation contre les infections pneumococciques chez l'enfant comportant un nombre réduit de doses de vaccin conjugué - édition révisée, 2005, Institut national de santé publique du Québec: Québec. p. 40.
19. Comité sur l'immunisation du Québec, Prévention par la vaccination des maladies attribuables aux virus du papillome humain, 2007, Institut national de santé publique du Québec: Québec. p. 76.
20. Dillman D.A. Mail and internet surveys-the tailored design method 2000, John Wiley & Sons, New York, 464 p. 2nd ed.
21. Hanlon J., Pickett G. Public health administration and practice 1984, Times Mirror/Mosby College Publishing, Santa Clara CA, p. 608. 8th ed.
22. Pickett G., Hanlon J.J. Public health administration and practice 1990, Times Mirror/Mosby College Publishing, St. Louis. 9th ed.
23. World Health Organization, Vaccine Introduction Guidelines - Adding a vaccine to a national immunization programme: decision and implementation. Available online at: , page consulted on December 20 2010. http://www.who.int/vaccines-documents/DocsPDF05/777_screen.pdf.
24. Douglas R.G. The Jeremiah Metzger lecture vaccine prophylaxis today: its science, application and politics. Transactions of the American Clinical and Climatological Association 1998, 109:185-196. [discussion 196-8].
25. Dubé E., Gilca V., Sauvageau C., Boulianne N., Boucher F., Bettinger J.A., et al. Determinants of Canadian physicians' intention to recommend rotavirus vaccines. Poster presentation. 28th Annual Meeting of the European Society for pediatric Infectious Diseases (ESPID) 2010.
26. National Advisory Committee on Immunization, Updated statement on the use of rotavirus vaccines. Canada Communicable Disease Report, 2010. 36(ACS-4): p. 1-37.
27. Gulli C. Our girls aren't guinea pigs 2007, Macleans, p. 38-42.
28. Keelan J., Pavri V., Balakrishnan R., Wilson K. An analysis of the human papilloma virus vaccine debate on MySpace blogs. Vaccine 2010, 28(6):1535-1540.
29. Calloway C., Jorgensen C.M., Saraiya M., Tsui J. A content analysis of news coverage of the HPV vaccine by U.S. newspapers: January 2002 to June 2005. J Womens Health (Larchmt) 2006, 15(7):803-809.
30. Oram R.J., Daum R.S., Seal J.B., Lauderdale D.S. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. Journal of American Medical Association 2001, 285(14):1874-1879.
31. Freed G.L., Bordley W.C., Clarks S.J., Konrad T.R. Reactions of pediatricians to a new centers for disease control recommendation for universal immunization of infants with hepatitis B vaccine. Pediatrics 1993, 91(4):699-702.
32. Raley J.C., Followwill K.A., Zimet G.D., Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infectious Diseases in Obstetrics and Gynecology 2004, 12(3-4):127-133.
33. Victor J.C., Brewster J.M., Ferrence R., Ashley M.J., Cohen J.E., Selby P. Tobacco-related medical education and physician interventions with parents who smoke: survey of Canadian family physicians and pediatricians. Canadian Family Physician 2010, 56(2):157-163.
34. Duval B., Gilca V., McNeil S., Dobson S., Money D., Gemmill I.M., et al. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 2007, 25(45):7841-7847.